Three-year efficacy and safety of tenofovir disoproxil fumarate monotherapy for multidrug-resistant chronic hepatitis B

Journal of Hepatology ◽

10.1016/s0168-8278(17)31860-3 ◽

2017 ◽

Vol 66 (1) ◽

pp. S693

Author(s):

S.Y. Kwon ◽

Y.-S. Lim ◽

Y.S. Lee ◽

G.-Y. Gwak ◽

K.S. Byun ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Multidrug Resistant ◽

Efficacy And Safety

Download Full-text

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

Yearbook of Gastroenterology ◽

10.1016/j.ygas.2011.07.095 ◽

2011 ◽

Vol 2011 ◽

pp. 242-243

Author(s):

D.M. Harnois

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety

Download Full-text

Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results

Hepatology International ◽

10.1007/s12072-019-09943-6 ◽

2019 ◽

Vol 13 (3) ◽

pp. 260-269 ◽

Author(s):

Xieer Liang ◽

Zhiliang Gao ◽

Qing Xie ◽

Jiming Zhang ◽

Jifang Sheng ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Chinese Patients ◽

Efficacy And Safety ◽

Download Full-text

IDDF2019-ABS-0169 A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results

10.1136/gutjnl-2019-iddfabstracts.278 ◽

2019 ◽

Author(s):

Henry Lik Yuen Chan ◽

Pietro Lampertico ◽

Maria Buti ◽

Scott Fung ◽

Sang Hoon Ahn ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide

Download Full-text

Week 96 Efficacy and Safety Results of Tenofovir Alafenamide (TAF) Comparing to Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B (CHB), HBEAG-Negative, Chronic Hepatitis B Patients: A Global Phase 3 Study

Gastroenterology ◽

10.1016/s0016-5085(17)33661-2 ◽

2017 ◽

Vol 152 (5) ◽

pp. S1086

Author(s):

Maurizia Rossana Brunetto ◽

Young-Suk Lim ◽

Edward Gane ◽

Wai-Kay Seto ◽

Marina Osipenko ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide ◽

Negative Chronic Hepatitis

Download Full-text

Week 96 Efficacy and Safety Results of Tenofovir Alafenamide (TAF) Comparing to Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B (CHB), HBEAG-Positive Patients: A Global Phase 3 Study

Gastroenterology ◽

10.1016/s0016-5085(17)33660-0 ◽

2017 ◽

Vol 152 (5) ◽

pp. S1085-S1086

Author(s):

Kosh Agarwal ◽

Scott Fung ◽

Wai-Kay Seto ◽

Young-Suk Lim ◽

Edward Gane ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide

Download Full-text

Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

Liver International ◽

10.1111/liv.14155 ◽

2019 ◽

Vol 39 (10) ◽

pp. 1868-1875 ◽

Author(s):

Patrick Marcellin ◽

David K Wong ◽

William Sievert ◽

Peter Buggisch ◽

Jörg Petersen ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B Virus ◽

Virus Infection ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Hepatitis B Virus Infection ◽

Efficacy And Safety ◽

Chronic Hepatitis B Virus ◽

Download Full-text

A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Negative, Chronic Hepatitis B: Week 48 Efficacy and Safety Results

Journal of Hepatology ◽

10.1016/s0168-8278(16)01637-8 ◽

2016 ◽

Vol 64 (2) ◽

pp. S135-S136 ◽

Author(s):

M. Buti ◽

E. Gane ◽

W.K. Seto ◽

H.L.Y. Chan ◽

W.-L. Chuang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide ◽

Negative Chronic Hepatitis

Download Full-text

A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96

Journal of Hepatology ◽

10.1016/s0168-8278(17)30313-6 ◽

2017 ◽

Vol 66 (1) ◽

pp. S25-S26 ◽

Author(s):

M. Brunetto ◽

Y.S. Lim ◽

E. Gane ◽

W.K. Seto ◽

M. Osipenko ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide ◽

Negative Chronic Hepatitis

Download Full-text

FRI-183-A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results

Journal of Hepatology ◽

10.1016/s0618-8278(19)30928-4 ◽

2019 ◽

Vol 70 (1) ◽

pp. e470-e471

Author(s):

Pietro Lampertico ◽

Maria Buti ◽

Scott Fung ◽

Sang Hoon Ahn ◽

Wan-Long Chuang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide

Download Full-text

Efficacy and Safety of Tenofovir Disoproxil Fumarate in Asian-Americans with Chronic Hepatitis B in Community Setting

PLoS ONE ◽

10.1371/journal.pone.0098723 ◽

2014 ◽

Vol 9 (5) ◽

pp. e98723

Author(s):

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Asian Americans ◽

Tenofovir Disoproxil Fumarate ◽

Community Setting ◽

Efficacy And Safety

Download Full-text